Clinical Trials Directory

Trials / Unknown

UnknownNCT05480839

Manual Immediately Sequential Bilateral Cataract Surgery (M-ISBCS) vs Refractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery (ReLA-ISBCS)

A Comparison of Patient Perceptions Undergoing Manual Immediately Sequential Bilateral Cataract Surgery (M-ISBCS) vs Refractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery (ReLA-ISBCS)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Uptown Eye Specialists · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The focus of this study is to assess the differences in patient perceptions of pain undergoing cataract surgery by using the Refractive Laser-Assisted Cataract Surgery (ReLACS) technique compared to the standard Manual Cataract Surgery (MCS) technique using an immediately sequential bilateral approach. This study also aims to further explore difference in patients' perceptions of pain depending on timing of neurolept anesthesia in the ReLACS technique. The importance of this study is appreciated patient perception of pain during ReLACS, which is an emerging technique for cataract surgery and has been sparsely reported on to date. This investigation will include the analysis of various surgical, ocular, medical, and psychosocial metrics of patients undergoing both ReLACS and MCS at Uptown Eye specialist.

Conditions

Interventions

TypeNameDescription
PROCEDUREM-IBCSManual Cataract Surgery - Phacoemulsification: removal of the eye lens and insertion of an intraocular lens implant
PROCEDUREReLA-IBCS EarlyRefractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery - ReLA-IBSCS with early administration of anesthesia
PROCEDUREReLA-ISBCSRefractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery - ReLA-IBSCS with standard administration of anesthesia

Timeline

Start date
2022-06-01
Primary completion
2022-08-31
Completion
2022-08-31
First posted
2022-07-29
Last updated
2022-07-29

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05480839. Inclusion in this directory is not an endorsement.